Webinar Date/Time: Wednesday, November 15th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Drug development processes can be enhanced utilizing modeling and simulation approaches provided by an expert modeling team. This webinar demonstrates how to properly apply modeling and simulation approaches to achieve efficiencies in your next drug development project.
Register Free:
https://www.appliedclinicaltrialsonline.com/act/statistical-modeling
Event overview
Drug development processes become more efficient, in terms of time and cost, with the assistance of modeling and simulation approaches widely utilized and accepted in the pharmaceutical industry. In addition, they are highly supported by regulators.
This presentation provides decision makers with an overview as to “why” modeling and simulation is important in the drug development industry. Several real-world examples that address the “what” approaches and explain “how” these approaches should be conducted to enhance the drug development process will be highlighted during the webinar.
Three key take-aways
Learn more about:
Speaker:
Zheng Liu, PhD
Director, Quantitative Clinical Pharmacology
IQVIA
Dr. Liu leads the PK/PD modeling team at IQVIA. He was trained as a mathematic modeling specialist, for which he holds a PhD, and has more than 10 years’ experience in PK/PD modeling field. Before he joined IQVIA in 2020, Dr Liu worked in Certara as a modeling consultant. In addition, he worked as a modeling expert for several institutes, including Melbourne Royal Children’s Hospital, University of Newcastle in Australia, Otago University in the New Zealand, and the International Atomic Energy Agency.
Register Free:
https://www.appliedclinicaltrialsonline.com/act/statistical-modeling
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.